Eli Lilly and Company, Moderna, UnitedHealth Group, Johnson & Johnson, and Intuitive Surgical are the five Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies involved in providing healthcare or developing and selling medical products and services, such as drugmakers, hospitals, medical-device firms, and health insurers. For investors, the category can offer exposure to healthcare demand and innovation, though individual stocks may be affected by factors such as regulation, research results, and insurance or drug-pricing policies. These companies had the highest dollar trading volume of any Healthcare stocks within the last several days.
Eli Lilly and Company (LLY)
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.
Shares of NYSE:LLY traded down $26.92 during trading on Thursday, hitting $1,391.07. 2,463,742 shares of the company's stock were exchanged, compared to its average volume of 2,947,631. The company has a market cap of $1.31 trillion, a price-to-earnings ratio of 45.25, a PEG ratio of 1.76 and a beta of 0.40. The company has a debt-to-equity ratio of 1.17, a current ratio of 1.39 and a quick ratio of 1.00. Eli Lilly and Company has a 52-week low of $850.51 and a 52-week high of $1,453.00. The business's 50-day simple moving average is $1,207.75 and its 200 day simple moving average is $1,097.85.
Read Our Latest Research Report on LLY
Moderna (MRNA)
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, autoimmune, and cardiovascular diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, influenza, and respiratory syncytial virus, spikevax, and hMPV/PIV3 vaccines; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; public health vaccines consists of Zika, Nipah, Mpox vaccines; and infectious diseases vaccines, such as lyme and norovirus vaccines.
MRNA traded down $19.53 during trading on Thursday, hitting $238.85. 7,023,851 shares of the company traded hands, compared to its average volume of 12,607,144. The company has a current ratio of 2.29, a quick ratio of 2.18 and a debt-to-equity ratio of 0.09. The company has a market cap of $95.36 billion, a PE ratio of -30.01 and a beta of 1.16. The stock's 50-day simple moving average is $187.78 and its two-hundred day simple moving average is $89.46. Moderna has a 1 year low of $22.28 and a 1 year high of $261.00.
Read Our Latest Research Report on MRNA
UnitedHealth Group (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
UNH stock traded down $11.38 during mid-day trading on Thursday, hitting $398.00. The company had a trading volume of 3,108,087 shares, compared to its average volume of 7,230,639. The company has a 50-day moving average price of $390.73 and a 200 day moving average price of $363.43. UnitedHealth Group has a 12-month low of $255.96 and a 12-month high of $461.62. The company has a market capitalization of $357.24 billion, a price-to-earnings ratio of 22.80, a P/E/G ratio of 1.46 and a beta of 0.51. The company has a quick ratio of 0.78, a current ratio of 0.74 and a debt-to-equity ratio of 0.66.
Read Our Latest Research Report on UNH
Johnson & Johnson (JNJ)
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension.
Shares of NYSE:JNJ traded down $0.59 during mid-day trading on Thursday, reaching $275.73. The stock had a trading volume of 4,132,770 shares, compared to its average volume of 7,944,761. The business's 50 day moving average price is $265.67 and its 200 day moving average price is $247.74. Johnson & Johnson has a 1 year low of $185.12 and a 1 year high of $282.02. The company has a market cap of $663.76 billion, a P/E ratio of 41.85, a price-to-earnings-growth ratio of 2.63 and a beta of 0.22. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 0.44.
Read Our Latest Research Report on JNJ
Intuitive Surgical (ISRG)
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
NASDAQ ISRG traded down $18.00 during trading on Thursday, hitting $464.10. 2,204,093 shares of the stock traded hands, compared to its average volume of 2,443,668. Intuitive Surgical has a 12-month low of $328.57 and a 12-month high of $603.88. The firm has a 50-day simple moving average of $406.25 and a 200-day simple moving average of $432.60. The company has a market capitalization of $160.88 billion, a P/E ratio of 56.20, a price-to-earnings-growth ratio of 3.04 and a beta of 1.45.
Read Our Latest Research Report on ISRG
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Eli Lilly and Company, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Eli Lilly and Company wasn't on the list.
While Eli Lilly and Company currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
